We are live on ! Find out more
PMVP icon

PMV Pharmaceuticals
PMVP

104 hedge funds and large institutions have $333M invested in PMV Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 41 increasing their positions, 33 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

148% more call options, than puts

Call options by funds: $3.98M | Put options by funds: $1.6M

24% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 33

3% more capital invested

Capital invested by funds: $324M → $333M (+$9.02M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

1.14% less ownership

Funds ownership: 113.06% → 111.92% (-1.1%)

2% less funds holding

Funds holding: 106 → 104 (-2)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

Holders
104
Holders Change
-2
Holders Change %
-1.89%
% of All Funds
1.65%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
8
Increased
41
Reduced
33
Closed
10
Calls
$3.98M
Puts
$1.6M
Net Calls
+$2.38M
Net Calls Change
+$2.28M

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$7.33M
2
Alkeon Capital Management
Alkeon Capital Management
New York
+$5.96M
3
TLP
Tri Locum Partners
New York
+$4.56M
4
OCA
Octagon Capital Advisors
New York
+$2.98M
5
GTC
Ghost Tree Capital
New York
+$2.92M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$4.5M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$4.44M
3
Citadel Advisors
Citadel Advisors
Florida
-$1.41M
4
SFM
Sphera Funds Management
Israel
-$1.18M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$1.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
51
RhumbLine Advisers
Massachusetts
$377K +$550 +80 +0.1%
Marshall Wace
52
Marshall Wace
United Kingdom
$357K +$399K +58,062 New
AllianceBernstein
53
AllianceBernstein
Tennessee
$328K +$30.1K +4,380 +9%
Los Angeles Capital Management
54
Los Angeles Capital Management
California
$275K -$122K -17,698 -28%
PP
55
PDT Partners
New York
$258K -$53.1K -7,725 -16%
Simplex Trading
56
Simplex Trading
Illinois
$241K +$197K +28,667 +268%
Jane Street
57
Jane Street
New York
$240K +$268K +39,034 New
Two Sigma Advisers
58
Two Sigma Advisers
New York
$238K -$439K -63,900 -62%
ECM
59
ExodusPoint Capital Management
New York
$235K +$263K +38,238 New
MFIM
60
Mesirow Financial Investment Management
Illinois
$213K – – –
Two Sigma Investments
61
Two Sigma Investments
New York
$209K -$178K -25,944 -43%
PI
62
PEAK6 Investments
Illinois
$200K +$223K +32,500 New
DA
63
Denali Advisors
California
$187K – – –
JAFL
64
Jay A. Fishman Ltd
Michigan
$184K – – –
HSBC Holdings
65
HSBC Holdings
United Kingdom
$184K -$57.6K -8,377 -21%
MAM
66
Martingale Asset Management
Massachusetts
$180K +$55K +8,000 +38%
Belvedere Trading
67
Belvedere Trading
Illinois
$180K +$33.6K +4,883 +20%
American Century Companies
68
American Century Companies
Missouri
$177K +$56K +8,146 +39%
D.E. Shaw & Co
69
D.E. Shaw & Co
New York
$177K -$223K -32,473 -53%
Millennium Management
70
Millennium Management
New York
$175K -$701K -101,990 -78%
AG
71
Algert Global
California
$171K +$191K +27,790 New
HighTower Advisors
72
HighTower Advisors
Illinois
$154K – – –
T. Rowe Price Associates
73
T. Rowe Price Associates
Maryland
$154K +$6.76K +983 +4%
MIM
74
MetLife Investment Management
New Jersey
$136K – – –
AIG
75
American International Group
New York
$118K +$4.71K +685 +4%
1 2
3
4 5

PMVP Hedge Fund Activity: Q3 2023 in Review

104 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in PMV Pharmaceuticals (PMVP) for Q3 2023, worth a combined $333M — up 2.8% from $324M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of PMVP and 8 opened new positions — a net loss of 2 holders — while 33 trimmed existing stakes and 41 added.

The largest buyer was PFM Health Sciences, adding an estimated $7.33M. The largest seller was RTW Investments, cutting an estimated $4.5M.

  • 104 institutional investors held PMV Pharmaceuticals (PMVP) as of Q3 2023, down from 106 in Q2 2023.
  • Funds reported $333M of PMV Pharmaceuticals stock for Q3 2023, up 2.8% quarter-over-quarter.
  • 8 funds opened new PMV Pharmaceuticals positions in Q3 2023 and 10 closed out, a net change of -2 holders.
  • The largest PMV Pharmaceuticals buyer in Q3 2023 was PFM Health Sciences, an estimated $7.33M added.
  • The largest PMV Pharmaceuticals seller in Q3 2023 was RTW Investments, an estimated $4.5M sold.

Based on aggregated 13F filings for Q3 2023.